19.09  0 (0%)		06-05 16:00
Open: 19.09 High: 19.09 Volume: 0		Pre. Close: 19.09 Low: 19.09 Market Cap: 118(M)

Short term
Mid term
Targets	6-month :	22.37	1-year :	26.13
Resists	First :	19.15	Second :	22.37
Pivot price	18.97
Supports	First :	18.94	Second :	18.81
MAs	MA(5) :	19.09	MA(20) :	18.94
	MA(100) :	18.68	MA(250) :	16.68
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	79.3	D(3) :	85.8
RSI	RSI(14): 75
52-week	High :	19.15	Low :	13.61

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ FONR ] has closed below upper band by 22.6%. Bollinger Bands are 33% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	19.13 - 19.23	19.23 - 19.31
Low:	18.82 - 18.95	18.95 - 19.06
Close:	18.91 - 19.1	19.1 - 19.26

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.

Sun, 19 Jul 2026
Fonar Corporation (FONR) Holds Flat as Shares Consolidate Between Support and Resistance - Volume Oscillator - dars.gov.et

Sat, 18 Jul 2026
FONAR (FONR) AGM 2026 Summary - Quartr

Sat, 18 Jul 2026
FONAR (FONR) Proxy Filing Summary - Quartr

Tue, 14 Jul 2026
Dimensional Fund Advisors cuts FONAR Corp (FONR) stake to 0% - Stock Titan

Thu, 04 Jun 2026
Fonar Completes Merger and Transitions to Private Company - The Globe and Mail

Thu, 21 May 2026
FONAR to be Taken Private After Supplemental Proxy Disclosures Ahead of May 28 Vote - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Equipment & Services
Shares Out	6 (M)
Shares Float	5 (M)
Held by Insiders	16.3 (%)
Held by Institutions	40.3 (%)
Shares Short	66 (K)
Shares Short P.Month	42 (K)

EPS	1
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	27.01
Profit Margin	6.3 %
Operating Margin	9.2 %
Return on Assets (ttm)	2.7 %
Return on Equity (ttm)	5.4 %
Qtrly Rev. Growth	-2.6 %
Gross Profit (p.s.)	6.87
Sales Per Share	17.07
EBITDA (p.s.)	2.23
Qtrly Earnings Growth	-37.1 %
Operating Cash Flow	8 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	19.09
PEG Ratio	0
Price to Book value	0.7
Price to Sales	1.11
Price to Cash Flow	15.37

Dividend	0.18
Forward Dividend	0
Dividend Yield	0.9%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.